Background:
Adnexal masses are often diagnosed in the pregnant patients. Ultrasonography is the first line modality for the determination of adnexal mass nature followed by contrast enhanced MRI assessment. However, these methods are not reliable methods for the detection of malignancy of ovarian masses. In vivo proton magnetic resonance spectroscopy is able to distinguish malignant and benign ovarian tumors.